FY25 B1 FSA mckesson FSA moud medication annual PR 0045

Ended Awarded Last action

Contract number
15B41225F00000004
Awardee
Awarding agency
Obligated
$83,365

Award facts

Contract value 100% obligated
$83,365.43 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Irving, TX 75039, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00004 -$737
Funding Only Action P00003 -$25,750
Funding Only Action P00002 -$2,447
Funding Only Action P00001 · FY25 B1 FSA mckesson FSA moud medication annual PR 0045 this MOD represents a funding only action for an increase of $52,300.00 $52,300
Original award $60,000

About this award

This modification represents a funding adjustment to a delivery order under the FY25 B1 FSA MCKESSON FSA MOUD Medication Annual contract, awarded to McKesson Corporation by the Federal Medical Center Rochester. The modification decreases total funding by $737.36, bringing the ceiling value to $83,365.43 under a firm fixed-price delivery order structure. The contract supports the provision of Medication-Assisted Opioid Use Disorder (MOUD) medications and related pharmaceutical products to Federal Medical Center Rochester, a civilian correctional healthcare facility operated by the Bureau of Prisons. The award date of October 23, 2024, with an ultimate completion date of September 30, 2025, indicates this is a fiscal year 2025 commitment. No small business set-aside was utilized for this contract action.

McKesson Corporation, a prominent pharmaceutical distribution and healthcare services company headquartered in Irving, Texas, continues its extensive engagement with federal healthcare agencies through this delivery order. The company maintains a substantial federal contract portfolio serving the Department of Justice's Bureau of Prisons, Department of Veterans Affairs, and the Department of Health and Human Services, among other agencies. The performance location in Irving, Texas reflects McKesson's central distribution capabilities, which enable efficient pharmaceutical supply chain management to correctional and federal medical facilities nationwide. This contract action supports the Bureau of Prisons' ongoing operational requirements for medication-assisted treatment programs within its correctional healthcare system.

Quick answers

Who was awarded contract 15B41225F00000004?

15B41225F00000004 was awarded to Mckesson Corporation by Federal Medical Center Rochester (Correctional Facilities) on October 23, 2024.

How much is contract 15B41225F00000004 worth?

The government has obligated $83,365 on 15B41225F00000004.

Is contract 15B41225F00000004 an order under another contract?

Yes. 15B41225F00000004 is a delivery order under 36W79720D0001, an indefinite delivery contract.

Was contract 15B41225F00000004 competed?

The extent of competition for 15B41225F00000004 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award